Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Int Wound J ; 16(5): 1239-1242, 2019 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-31353778

RESUMEN

Pyoderma gangrenosum (PG) is a rare auto-inflammatory, neutrophilic, ulcerative disorder characterised by acutely painful, rapidly spreading, sterile ulcers over the trunk and lower limbs. The pathogenic mechansim of PG is under constant evolution and drugs are emerging to be a an important trigger. In the literature, 52 cases of drug-induced PG have been documented, of which cocaine laced with levamisole has shown most direct association, with a mean Naranjo score of 9. Other drugs probably associated with PG are isotretinoin, sunitinib, and propylthiouracil. We describe a case of a 59-year-old male who had multiple well-defined ulcers with a violaceous, undermined edge limited to the site of subcutaneous injection of insulin. Histopathological examination showed psoriasiform hyperplasia in the epidermis, with abundant infiltration of neutrophils in the dermis, consistent with the clinical diagnosis of PG. As per the modified Naranjo algorithm, the patient's total score was 7, indicating insulin to be the probable causative agent in our case. So, compiling temporal localisation of lesions to the site of administration of insulin and clinical, histopathological, and Naranjo score evidence all prompt the diagnosis of PG. Insulin stimulates the release of matrix-metalloproteinases 9 which acts as endopeptidases and also results in the chemotaxis of neutrophils, causing ulcer formation. This is the first case reporting PG triggered by insulin.


Asunto(s)
Corticoesteroides/administración & dosificación , Diabetes Mellitus Tipo 2/tratamiento farmacológico , Insulina/efectos adversos , Piodermia Gangrenosa/inducido químicamente , Piodermia Gangrenosa/tratamiento farmacológico , Biopsia con Aguja , Diabetes Mellitus Tipo 2/diagnóstico , Sustitución de Medicamentos , Humanos , Inmunohistoquímica , Inyecciones Subcutáneas/efectos adversos , Insulina/uso terapéutico , Masculino , Persona de Mediana Edad , Piodermia Gangrenosa/patología , Enfermedades Raras , Medición de Riesgo , Índice de Severidad de la Enfermedad , Resultado del Tratamiento , Privación de Tratamiento
3.
Indian J Dermatol ; 53(4): 201-3, 2008.
Artículo en Inglés | MEDLINE | ID: mdl-19882037

RESUMEN

Macular amyloidosis is a common problem seen dermatology out-patient department. Generalized macular amyloidosis presenting with a poikilodermatous appearance is rare. In our case, an 18-year-old male presented with generalized hypopigmented macules with a poikilodermatous appearance of 10-year duration. His developmental milestones were normal with negative family history of similar complaints. Histopathology of hyperpigmented lesions revealed hyperkeratosis and acanthosis of epidermis and hypopigmented lesion showing only hyperkeratosis. Both lesions were showing the deposition of amorphous, hazy material in the tips of papillary dermis with perivascular inflammatory infiltrate. Congo red staining of the amorphous material was positive for amyloid.

SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA